Next 10 |
2024-07-18 04:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Atlantic Coastal Acquisition Corp. II Receives Notification of Deficiency from Nasdaq Related to Delayed Quarterly Report on Form 10-Q PR Newswire NEW YORK , June 13, 2024 /PRNewswire/ -- Atlantic Coastal Acquisition Corp. II (NASDAQ: ACAB) (the "Company"), a special pur...
WOBURN, Mass. and NEW YORK, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Abpro Corporation (“Abpro”), a biotech company with the mission of improving the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies, and Atlantic Coastal Acquisition Corp....
2024-01-14 22:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Atlantic Coastal Acquisition Corp. II Announces Extension of Business Combination Period and Additional Contribution to Trust Account PR Newswire NEW YORK , Oct. 18, 2023 /PRNewswire/ -- Atlantic Coastal Acquisition Corp. II (NASDAQ: ACAB) (the "Company"), a spec...
2023-09-21 16:14:13 ET More on Atlantic Coastal Acquisition Corp. II Financial information for Atlantic Coastal Acquisition Corp. II For further details see: Biotechnology company Abpro to merge with SPAC Atlantic Coastal Acquisition
IMPORTANT: Atlantic Coastal Acquisition Corp. Files Definitive Proxy Statement in Connection with Plan to Extend the Amount of Time the Company has to Consummate a Business Combination PR Newswire NEW YORK , Sept. 6, 2023 /PRNewswire/ -- Atlantic Coastal Acq...
Atlantic Coastal Acquisition Corp. Announces Plans to Extend Deadline to Complete Initial Business Combination. PR Newswire The Company Also Received a Notice of Non-compliance from Nasdaq for Failure to Timely File its Second Quarter 2023 Form 10-Q NEW YORK , ...
Atlantic Coastal Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Quarterly Report on Form 10-Q PR Newswire NEW YORK , May 30, 2023 /PRNewswire/ -- Atlantic Coastal Acquisition Corp. (NASDAQ: ACAH) (the "Company"), a special pu...
Atlantic Coastal Acquisition Corp. II raised $300 million in an IPO in January 2022. The SPAC seeks to merge with a firm in the next generation mobility space. Given the team’s lack of successful track record in SPACs and recent failed merger attempt in its first SPAC, my o...
News, Short Squeeze, Breakout and More Instantly...
Atlantic Coastal Acquisition Corp. II Company Name:
ACAB Stock Symbol:
NASDAQ Market:
2024-07-18 04:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Atlantic Coastal Acquisition Corp. II Receives Notification of Deficiency from Nasdaq Related to Delayed Quarterly Report on Form 10-Q PR Newswire NEW YORK , June 13, 2024 /PRNewswire/ -- Atlantic Coastal Acquisition Corp. II (NASDAQ: ACAB) (the "Company"), a special pur...
WOBURN, Mass. and NEW YORK, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Abpro Corporation (“Abpro”), a biotech company with the mission of improving the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies, and Atlantic Coastal Acquisition Corp....